Affiliation:
1. Research Center for Social Determinants of Health, Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran Iran
2. Department of Epidemiology and Biostatics, Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran Iran
3. Endocrine Research Center, Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran Iran
Abstract
Background
For the first time, the present study investigated smoking trajectory and cardiometabolic profile from adolescence to young adulthood in a middle‐income developing country facing a high prevalence of smoking and cardiovascular disease‐related outcomes.
Methods and Results
Data on 1082 adolescents (12–18 years of age) who participated in the TLGS (Tehran Lipid and Glucose Study) were gathered, and participants were followed for a median of 12.5 years (baseline: 1999–2002, last follow‐up: 2014–2017). Participants were categorized as non/rare smokers, experimenters, and escalators using group‐based trajectory models. Statistical analysis was used to compare the trajectory groups' cardiometabolic components, clinical characteristics, and cardiometabolic changes due to the individuals' placement in experimenter and escalator groups compared with non/rare smokers. The smoking trajectory groups in young adulthood differ significantly in blood pressure, triglycerides, high‐density lipoprotein cholesterol, waist circumference, and body mass index, with the escalator group having the highest risk values for each component. Significant differences were observed in blood pressure (
P
=0.014), triglycerides (
P
<0.001), and waist circumference (
P
<0.001) status after using clinical cut points. The adjusted linear regression revealed that the escalator group had 3.16 mm Hg‐lower systolic blood pressure SBP (
P
=0.016), 2.69 mm Hg‐lower diastolic blood pressure (
P
=0.011), and 4.42 mg/dL‐lower high‐density lipoprotein cholesterol (
P
=0.002), compared with the non/rare smoker group.
Conclusions
Despite elevated risks in unadjusted analyses for all cardiometabolic components among smokers, our study identified a modest protective link between early smoking and blood pressure in addition to a remarkable harmful association with high‐density lipoprotein cholesterol levels exclusively in the escalator group during the developmental stage to young adulthood, using adjusted analyses.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference48 articles.
1. WHO . Cardiovascular diseases (CVDs). Accessed June 11 2021. https://www.who.int/news‐room/fact‐sheets/detail/cardiovascular‐diseases‐(cvds).
2. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990–2013: a systematic analysis of data from the Global Burden of Disease Study 2013: cardiovascular topic
3. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention;Sarrafzadegan N;Arch Iranian Med,2019
4. Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025: the impact of demographic changes;Sadeghi M;Iranian J Public Health,2017
5. The Global Burden of Cardiovascular Diseases and Risk